Work

Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity

Year: 2013

Type: article

Source: Experimental Hematology

DOI: 10.1016/j.exphem.2013.04.012

Authors: Siddhartha Sen, Duane C. Hassane, Cheryl Corbett, Michael W. Becker, Craig T. Jordan, Monica L. Guzman

Institutions: Cornell University, Weill Cornell Medicine, University of Rochester Medicine, University of Rochester

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G2849863736, G7979705340, Selection of Novel Therapies to Ablate Chemoresistant Myeloid Leukemia Stem Cell

OpenAlex ID: W2096215902

FWCI: 1.882

Cites: 52

Cited by: 40

Related to: 10